Ubs Group Ag Apyx Medical Corp Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Apyx Medical Corp stock. As of the latest transaction made, Ubs Group Ag holds 4,308 shares of APYX stock, worth $9,520. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,308
Previous 3,851
11.87%
Holding current value
$9,520
Previous $6,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
18 transactions
Others Institutions Holding APYX
# of Institutions
50Shares Held
17.4MCall Options Held
60.3KPut Options Held
1K-
Archon Capital Management LLC Seattle, WA3.3MShares$7.29 Million5.28% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.26MShares$7.2 Million0.2% of portfolio
-
Royce & Associates LP2.53MShares$5.58 Million0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.48MShares$3.26 Million0.0% of portfolio
-
Invenire Partners, LP Ridgefield, CT946KShares$2.09 Million100.0% of portfolio
About Apyx Medical Corp
- Ticker APYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 34,573,000
- Market Cap $76.4M
- Description
- Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ab...